Cost-Effectiveness Analysis of Lurasidone and Olanzapine in the Treatment of Schizophrenia
Value in Health - United Kingdom
doi 10.1016/j.jval.2016.03.1380
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2016
Authors
Publisher
Elsevier BV